Keywords: Life sciences


Thermo Fisher targets 15%-20% customer growth in India as biopharma sector expands

Thermo Fisher Scientific expects its customer base in India to grow by 15% to 20% over the next five years, as expanding biopharmaceutical research and manufacturing activity drives demand for laboratory and drug-development technologies. The US-based life sciences company is targeting continued double-digit......

Dassault Systèmes boosts first-half profit as AI-driven acquisition strengthens life sciences strategy

Dassault Systèmes has combined a strong improvement in first-half profitability with one of its largest strategic acquisitions in recent years, reinforcing its ambitions to expand the role of artificial intelligence in the life sciences software market. The French technology company reported......

Bayer secures €3 billion from Apollo in contraceptives business investment deal

German pharmaceutical and life sciences group Bayer has secured €3 billion ($3.4 billion) in equity financing through an agreement with funds managed by Apollo Global Management, strengthening its capital structure while retaining control of one of its key healthcare businesses. Announced on Friday,......

Qiagen attracts early takeover interest from EQT, advent and KKR, report says

German diagnostics and life sciences company Qiagen has reportedly attracted preliminary takeover interest from several major private equity firms, according to a report published by Bloomberg News on Thursday. Citing people familiar with the matter, Bloomberg said that investment groups EQT, Advent......

Anthropic enters scientific AI race with launch of Claude Science

Anthropic has unveiled Claude Science, a new artificial intelligence platform developed specifically for researchers, life science organizations, and pharmaceutical companies, marking the company's latest move to expand its presence in the enterprise AI market. The announcement was made during......

OpenAI unveils GPT-Rosalind to accelerate life sciences research

OpenAI has introduced GPT-Rosalind, a reasoning model designed for life sciences research, marking the company’s first major move into scientific AI tools focused on genomics, drug discovery, and protein engineering. The release came alongside a broad update to its Codex coding agent, which gained......